NCT07658625

Brief Summary

Previous studies have provided a preliminary understanding of the likelihood of sarcopenia and the prevalence of sarcopenia in the elderly in the community. due to the interaction between physiological and social factors, this study aims to conduct a correlation study on muscle mass, oral function and social frailty in the elderly living in the community. This study,the Makizako social frailty screening index questionnaire and the Tilburg Frailty Indicator will be used to assess the social frailty status of the study participants. Correlation analysis with sarcopenia and oral dysfunction was also conducted to better understand the interaction between nutrition, physiology, and social connection in the elderly, which will be helpful for formulating relevant policies and promoting healthy aging in the future in extremely elderly countries.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 14, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 4, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 4, 2026

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

June 10, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

June 22, 2026

Completed
Last Updated

June 22, 2026

Status Verified

June 1, 2026

Enrollment Period

7 months

First QC Date

June 10, 2026

Last Update Submit

June 15, 2026

Conditions

Keywords

SarcopeniaPoor oral functionSocial weaknesschewNutrition

Outcome Measures

Primary Outcomes (1)

  • Based on the results of empirical research on sarcopenia in Asian countries, a diagnostic consensus was established.

    * The cut-off point for abnormal grip strength is less than 28 kg for men and less than 18 kg for women * 6-meter walking speed less than 1.0 second/meter * 5-time chair stand test greater than or equal to 12 seconds * Short physical performance battery, SPPB greater than or equal to 9 points The above will be combined to determine whether sarcopenia is possible.

    Baseline

Study Arms (2)

Group A

Possible sarcopenia

Other: Non interventional study

Group B

Non-possible sarcopenia

Other: Non interventional study

Interventions

NON

Group AGroup B

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Care centers in Taoyuan City and various districts of New Taipei City

You may qualify if:

  • years old or above
  • general public or institutionalized for 3 months or more
  • those who accept the experimental design and are willing to sign the consent form
  • dietary sources are oral intake
  • those who are diagnosed as having possible sarcopenia by researchers
  • years old or above
  • general public or institutionalized for 3 months or more
  • those who accept the experimental design and are willing to sign the consent form
  • dietary sources are oral intake
  • those who were determined by researchers to be non-probable sarcopenia

You may not qualify if:

  • comorbidities, critical illness, pre- and post-major surgery, cancer, renal failure, liver failure, kidney disease, liver disease, malignant tumors within the past five years, inflammatory conditions (c-reactive protein \>10mg/dL)
  • severely malnourished people
  • long-term force-feeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chang Gung University of Science and Technology

Taoyuan, Taiwan

Location

MeSH Terms

Conditions

Sarcopenia

Condition Hierarchy (Ancestors)

Muscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and Symptoms

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 10, 2026

First Posted

June 22, 2026

Study Start

November 14, 2025

Primary Completion

June 4, 2026

Study Completion

June 4, 2026

Last Updated

June 22, 2026

Record last verified: 2026-06

Locations